Assembly Biosciences, Inc.

BST:V7B Stock Report

Market Cap: €67.0m

Assembly Biosciences Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

BST:V7B Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
30 Apr 24Sell€18,645Jason OkazakiIndividual1,569€11.88
30 Apr 24Sell€14,914Nicole WhiteIndividual1,255€11.88
01 Apr 24Sell€4,308Jason OkazakiIndividual354€12.17
01 Apr 24Sell€2,397Nicole WhiteIndividual197€12.17
01 Apr 24Sell€1,387Jeanette BjorkquistIndividual114€12.17
01 Apr 24Sell€14,677John McHutchisonIndividual1,206€12.17
27 Mar 24Sell€4,663Jason OkazakiIndividual392€11.89
18 Jan 24Buy€470,567Alexander SchornsteinIndividual53,756.65€8.84
21 Nov 23Buy€258,150Alexander SchornsteinIndividual33,333.32€7.88
17 Nov 23Sell€302Nicole WhiteIndividual39.75€7.59
16 Oct 23Buy€14,379,884Gilead Sciences, Inc.Company1,089,471.9€13.20
03 Oct 23Sell€1,796Jason OkazakiIndividual196.92€9.12
03 Oct 23Sell€1,437William DelaneyIndividual157.58€9.12
03 Oct 23Sell€1,437Nicole WhiteIndividual157.58€9.12
02 Aug 23Sell€11,765Jason OkazakiIndividual985.58€11.94
02 Aug 23Sell€9,412William DelaneyIndividual788.42€11.94
24 Jul 23Sell€813Jeanette BjorkquistIndividual70.33€11.56
30 May 23Sell€3,774William DelaneyIndividual352.67€10.70
23 May 23Sell€6,335Jason OkazakiIndividual546.75€11.59
23 May 23Sell€6,335William DelaneyIndividual546.75€11.59
23 May 23Sell€265Jeanette BjorkquistIndividual22.83€11.59
23 May 23Sell€25,079John McHutchisonIndividual2,164.33€11.59

Insider Trading Volume

Insider Buying: V7B insiders have only sold shares in the past 3 months.


Ownership Breakdown

What is the ownership structure of V7B?
Owner TypeNumber of SharesOwnership Percentage
Private Companies1,0810.0197%
Institutions746,45713.6%
Individual Insiders766,55214%
Public Companies1,089,47219.9%
General Public2,879,19052.5%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 26.2%.


Top Shareholders

Top 25 shareholders own 46.56% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
19.9%
Gilead Sciences, Inc.
1,089,472€13.3m0%no data
12.5%
Alexander Schornstein
684,114€8.4m8.53%no data
3.56%
The Vanguard Group, Inc.
194,923€2.4m4.42%no data
2.2%
Millennium Management LLC
120,837€1.5m2.84%no data
1.44%
BlackRock, Inc.
78,998€965.0k-10.8%no data
1.09%
Anson Group
59,955€732.4k0%0.13%
0.93%
Geode Capital Management, LLC
51,000€623.0k26.1%no data
0.65%
Renaissance Technologies LLC
35,876€438.2k-12.8%no data
0.59%
Charles Schwab Investment Management, Inc.
32,452€396.4k1,100%no data
0.49%
Richard DiMarchi
26,603€325.0k0%no data
0.46%
Federated Hermes, Inc.
25,394€310.2k-10.9%no data
0.4%
Acuitas Investments, LLC
22,132€270.3k0%0.11%
0.26%
Bridgeway Capital Management, LLC
14,499€177.1k0%no data
0.22%
State Street Global Advisors, Inc.
12,111€147.9k0%no data
0.22%
John McHutchison
11,795€144.1k4.77%no data
0.21%
FMR LLC
11,361€138.8k-0.42%no data
0.21%
Two Sigma Investments, LP
11,253€137.5k0%no data
0.2%
Northern Trust Global Investments
10,931€133.5k21.3%no data
0.19%
Citadel Advisors LLC
10,409€127.1k-9.85%no data
0.19%
Jason Okazaki
10,253€125.2k59.6%no data
0.18%
William Delaney
9,938€121.4k69.8%no data
0.16%
Nicole White
8,924€109.0k180%no data
0.14%
Amundi Asset Management SAS
7,934€96.9k0%no data
0.11%
Susquehanna International Group, LLP, Asset Management Arm
5,980€73.0k0%no data
0.11%
Acadian Asset Management LLC
5,868€71.7k-15.6%no data
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.